Shear Wave Elastography: How well does it perform in Chronic Hepatitis D Virus Infection?

Alexander H. Yang,David Yardeni,Julian Hercun,David E. Kleiner,Alexander Ling,Jamie Marko,Theo Heller,Christopher Koh
DOI: https://doi.org/10.1111/jvh.13745
2022-09-06
Journal of Viral Hepatitis
Abstract:Hepatitis delta virus (HDV) infection is associated with accelerated progression of liver disease to cirrhosis. Shear wave elastography (SWE) is a non‐invasive evaluation method of liver fibrosis. Its performance in accurately characterizing HDV fibrosis compared to other noninvasive markers remains unknown. We assessed the performance of SWE in patients with chronic HDV, Hepatitis B (HBV) and Hepatitis C (HCV) infection. Cirrhosis was determined by histology or clinical data. Area under receiver operator characteristics (AUROC) was used to assess diagnostic performance in identifying cirrhosis by SWE in comparison to Fibroscan® (VCTE) and serologic tests of fibrosis. 158 patients with chronic hepatitis (HDV:44%, HBV: 46%, HCV: 29%) were evaluated. Cirrhosis was diagnosed in 28 (17.7%) patients. Mean noninvasive fibrosis measurements for the HBV/HCV and HDV groups respectively were: APRI: 0.73±1.08 and 1.3 ± 1.38; FIB‐4: 1.90±2.24 and 2.33±2.24; VCTE: 8.9 ± 6.7 kPa vs 10.4 ±5.3 kPa; SWE: 1.5 ±0.2m/s and 1.6 ±0.2m/s. The performance of SWE in detecting HDV induced cirrhosis (AUROC 0.84, 95% CI 0.71‐0.97) was slightly lower than in HBV/HCV induced disease (AUROC 0.88, 95% CI 0.81‐0.96). For HDV patients, the performance of SWE was comparable to VCTE and slightly better than APRI and FIB‐4 especially in APRI and FIB‐4 indeterminate zones. The overall less accurate performance of noninvasive markers in HDV in comparison to HBV and HCV may be a result of significant hepatic inflammation in HDV.
gastroenterology & hepatology,infectious diseases,virology
What problem does this paper attempt to address?